# Earth Science Tech, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Earth Science Tech, Inc.). ## Overview Earth Science Tech, Inc. is a U.S.-based healthcare and wellness company operating through subsidiaries including Peaks, DOC, Villas, RxCompoundstore, Avenvi, and Mister Meds. Its business spans telehealth, pharmacy/compounding, and related wellness offerings, with revenue driven by customer acquisition, brand building, and the ability to keep patients engaged across a fast-changing digital health market. ## Products & services • Telehealth services through Peaks, DOC, and Villas • Pharmacy and compounded prescription fulfillment • Wellness and condition-specific healthcare offerings • Patient acquisition and engagement via digital marketing • Inventory-based order fulfillment from RxCompound and Mister Meds - **Telehealth services** (45%) — Virtual healthcare offerings delivered through the company's telehealth brands and provider network. - **Pharmacy and compounding** (30%) — Prescription fulfillment and compounded medication services handled through pharmacy operations. - **Wellness and related services** (15%) — Consumer-facing wellness and condition-focused offerings marketed through the platform. - **Marketing and customer acquisition** (10%) — Digital marketing, influencer, and brand-led demand generation that supports customer growth. - Telehealth services through Peaks, DOC, and Villas - Pharmacy and compounded prescription fulfillment - Wellness and condition-specific healthcare offerings - Patient acquisition and engagement via digital marketing - Inventory-based order fulfillment from RxCompound and Mister Meds ## Customers The company serves consumers seeking telehealth, pharmacy, and wellness solutions, with demand driven by convenience, access, and brand trust. Its customer base also includes patients using condition-specific services offered through affiliated healthcare providers and pharmacy channels. Growth depends on attracting new users, retaining existing customers, and maintaining market acceptance in a competitive digital health environment. - **Telehealth patients** (primary) — Patients using Peaks, DOC, and Villas for virtual consultations and ongoing care. - **Pharmacy customers** (primary) — Customers filling prescriptions or compounded medications through RxCompound and Mister Meds. - **Wellness consumers** (secondary) — Consumers buying wellness-related offerings marketed through the company's brands and social channels. - **Condition-specific care users** (secondary) — Patients seeking treatment for specific conditions available through the platform's provider network. - Consumers seeking convenient telehealth access and ongoing care - Patients needing pharmacy or compounded prescription fulfillment - Wellness-oriented customers drawn by brand and digital marketing - Users of condition-specific services delivered through affiliated providers - Repeat customers whose retention supports recurring revenue ## Geography The company is headquartered in the United States and its disclosed operations are centered there. The reports specifically mention inventory housed in Miami, Florida and Abilene, Texas, which makes U.S. logistics and facility continuity important to service levels. No country-level revenue split was disclosed in the provided excerpts. - United States is the core operating and customer market - Inventory is stored at facilities in Miami, Florida and Abilene, Texas - U.S. healthcare and marketing regulation directly affects operations - No country-level revenue disclosure was provided in the excerpts ## Strategy Management is focused on expanding the scope of offerings, growing the number and quality of healthcare providers, and increasing the conditions that can be treated through the platform. The company also emphasizes brand building, digital marketing, and customer retention because its model depends on awareness, trust, and repeat engagement. Operational resilience at its pharmacy and fulfillment sites is also strategically important because service continuity supports customer experience and growth. - **Broaden the offering set** (medium-term) — More products, services, and treatable conditions can increase customer lifetime value and market reach. - **Improve customer acquisition and retention** (short-term) — Revenue depends on marketing effectiveness, platform engagement, and repeat usage. - **Protect operating continuity** (short-term) — Centralized inventory and affiliated-provider operations create service and reputational risk if disrupted. - Expand products, services, and treatable conditions - Grow and retain customers through digital marketing and brand building - Strengthen provider network and affiliated healthcare relationships - Maintain reliable pharmacy fulfillment and inventory operations - Pursue acquisitions or partnerships to accelerate growth ## Risks The business is exposed to customer acquisition risk, regulatory risk, and brand/reputation risk because its model relies on digital marketing, healthcare compliance, and consumer trust. It also faces execution risk from centralized inventory locations, affiliated-provider conduct, and competition from larger healthcare and pharmacy players. As a smaller reporting company in a rapidly evolving market, quarterly volatility and acquisition/integration risk are also meaningful. - **Customer acquisition and retention failure** [high] — The company says growth depends on marketing and platform engagement; weak demand generation would hurt revenue. - **Healthcare, privacy, and advertising regulation** [high] — Changes in laws can restrict outreach, increase compliance costs, or trigger penalties. - **Brand and reputational damage** [high] — The company relies heavily on brand strength and social/influencer marketing, which can backfire if misused. - **Centralized inventory disruption** [high] — Inventory is housed at two facilities; damage or interruption could impair order fulfillment. - **Competition from larger healthcare and pharmacy companies** [medium] — Better-capitalized rivals may outspend the company on marketing, technology, and provider networks. - Customer acquisition or retention weakness can reduce revenue growth - Healthcare, privacy, and advertising rules can limit marketing reach - Brand damage from influencer misuse or provider misconduct can hurt demand - Centralized inventory sites create fulfillment disruption risk - Competition from larger healthcare and pharmacy players is intense ## Accounting Revenue is recognized under ASC 606 when performance obligations are satisfied, with product sales recognized at point of sale or shipment depending on terms. Investors should watch for quarter-to-quarter volatility, fair value changes in equity securities, and impairment testing for goodwill and long-lived assets, since these areas can materially affect reported earnings. The company also discloses no contract assets or liabilities, which suggests limited deferred revenue complexity but does not remove judgment around estimates, contingencies, and going-concern assessment. - **Revenue recognition timing** — Can shift revenue between periods depending on fulfillment terms - **Goodwill impairment** — Potential non-cash charges to earnings - **Fair value of equity securities** — Can create volatility in net income - **Estimates and contingencies** — Affects reserves, depreciation/amortization, and reported risk profile - Revenue recognized at point of sale or shipment under ASC 606 - No contract assets or liabilities were disclosed - Goodwill impairment testing can affect reported earnings - Fair value changes in equity securities flow through earnings - Quarterly results may fluctuate materially from marketing and demand swings --- *Last updated: 2026-04-28T20:04:14.465487+00:00*